Potential conflicts of interest: Dr. Goetz, Consulting and Advisory Board Membership in the past 3 years: Biogen, Boehringer-Ingelheim, Cerogene, EMD Pharmaceuticals, Impax Pharmaceuticals, I3 Research, Juvantia Pharmaceuticals, Kiowa Pharmaceuticals, GlaxoSmith Kline, Merck KgaA, Merck and Co, Neurim Pharmaceuticals, Novartis Pharmaceuticals, Ovation Pharmaceuticals, Oxford Biomedica, Schering-Plough, Solstice Neurosciences, Solvay Pharmaceuticals, Synergy/Intec, Teva Pharmaceuticals. He has received funding from NIH, Michael J. Fox Foundation, and directs the Rush Parkinson's Disease Research Center that receives support from the Parkinson's Disease Foundation. Dr. Stebbins, Consulting and Advisory Board Membership in the past three years: Boehringer-Ingelheim, Novartis Pharmaceuticals. He has received funding from NIH, the Michael J. Fox Foundation, the Fragile X Foundation and the Kinetics Foundation. Dr. Nutt, Consulting and Advisory Board Positions: IMPAX Laboratories, Schering-Plough Research, Xenoport, Inc. Research funding: NIH, MJFF, Kinetics Fdn, Ceregene, and National Parkinson Foundation. Dr. Nutt directs the Movement Disorder Program at OHSU and co-directs the PADRECC at the Portland VA.
Teaching program for the Unified Dyskinesia Rating Scale†
Article first published online: 7 MAY 2009
Copyright © 2009 Movement Disorder Society
Volume 24, Issue 9, pages 1296–1298, 15 July 2009
How to Cite
Goetz, C. G., Nutt, J. G., Stebbins, G. T. and Chmura, T. A. (2009), Teaching program for the Unified Dyskinesia Rating Scale. Mov. Disord., 24: 1296–1298. doi: 10.1002/mds.22563
- Issue published online: 24 JUL 2009
- Article first published online: 7 MAY 2009
- Manuscript Accepted: 3 MAR 2009
- Manuscript Received: 6 FEB 2009
- Michael J Fox Foundation
- EMD/Merck KGaA Pharmaceuticals
- Santhera Pharmaceuticals
- i3 Research Inc.
- Rush Movement Disorder Program is a Parkinson's Disease Foundation Research Center
- OHSU Movement Disorder Program is a National Parkinson Disease Center of Excellence
Options for accessing this content:
- If you have access to this content through a society membership, please first log in to your society website.
- If you would like institutional access to this content, please recommend the title to your librarian.
- Login via other institutional login options http://onlinelibrary.wiley.com/login-options.
- You can purchase online access to this Article for a 24-hour period (price varies by title)
- If you already have a Wiley Online Library or Wiley InterScience user account: login above and proceed to purchase the article.
- New Users: Please register, then proceed to purchase the article.
Login via OpenAthens
Search for your institution's name below to login via Shibboleth.
Registered Users please login:
- Access your saved publications, articles and searches
- Manage your email alerts, orders and subscriptions
- Change your contact information, including your password
Please register to:
- Save publications, articles and searches
- Get email alerts
- Get all the benefits mentioned below!
Patients and/or caregivers may access this content for use in relation to their own personal healthcare or that of a family member only. Terms and conditions will apply.